1. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
    Masao Tanaka et al, 2017, Pancreatology CrossRef
  2. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy
    Max Heckler et al, 2017, Pancreatology CrossRef
  3. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
    Grace H Elta et al, 2018, Am J Gastroenterol CrossRef
  4. European evidence-based guidelines on pancreatic cystic neoplasms
    , 2018, Gut CrossRef
  5. Pancreatic Cystic Neoplasms: Different Types, Different Management, New Guidelines
    Lianne Scholten et al, 2018, Visc Med CrossRef
  6. Circulating Thrombospondin-2 Enhances Prediction of Malignant Intraductal Papillary Mucinous Neoplasm
    Rachel E. Simpson et al, 2018, The American Journal of Surgery CrossRef
  7. Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives
    IJM Levink et al, 2018, Curr Treat Options Gastro CrossRef
  8. Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade
    Michele T. Yip-Schneider et al, 2018, J Gastrointest Surg CrossRef
  9. Invasive Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Causing Duodenal Infiltration and Obstruction: a Case Report
    Narendra Pandit et al, 2019, J Gastrointest Canc CrossRef
  10. Association between GPX3 promoter methylation and malignant tumors: a meta-analysis
    Cong Zhou et al, 2019, Pathology - Research and Practice CrossRef
  11. Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer
    Rogier Aäron Gaiser et al, 2019, Sci Rep CrossRef
  12. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia
    Rachel E. Simpson et al, 2019, Pancreas CrossRef
  13. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less
    W. Jung et al, 2019, Br J Surg CrossRef
  14. Intraductal papillary mucinous neoplasms
    Klaus Sahora et al, 2015, Current Opinion in Gastroenterology CrossRef
  15. The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms
    Kota Arima et al, 2015, J Gastrointest Surg CrossRef
  16. Pancreatic resection for intraductal papillary mucinous neoplasm– a thirteen-year single center experience
    Katharina Marsoner et al, 2016, BMC Cancer CrossRef
  17. Clinical problems of IPMN from three clinical guidelines and meta-analyses for IPMN
    Koji YAMAGUCHI, 2017, Journal of the Japan Pancreas Society CrossRef
  18. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)
    Joseph Carmicheal et al, 2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  19. Cystic Lesions of the Pancreas: Differential Diagnosis and Cytologic-Histologic Correlation
    Amrou Abdelkader et al, 2020, Archives of Pathology & Laboratory Medicine CrossRef
  20. An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN
    D. Ciprani et al, 2020, Pancreatology CrossRef
  21. Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas
    Wataru Izumo et al, 2020, Pancreatology CrossRef
  22. null
    Stephen Hasak et al, 2020 CrossRef
  23. A retrospective study of histological outcome for IPMN after surgery in Lausanne, Switzerland: A case series
    Alexis Litchinko et al, 2020, Annals of Medicine and Surgery CrossRef
  24. Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas
    Marco Del Chiaro et al, 2020 CrossRef
  25. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel
    Elizabeth M. Hecht et al, 2020, Abdom Radiol CrossRef
  26. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas
    Li-Qi Sun et al, 2021, WJG CrossRef
  27. Nomogram for the Prediction of High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on Variables of Noninvasive Examination
    Bo Li et al, 2021, Front. Oncol. CrossRef
  28. Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection
    Ann Morgell et al, 2021, J. Proteome Res. CrossRef
  29. A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions
    Margaret G. Keane et al, 2021, JCM CrossRef
  30. null
    David Anz et al, 2021 CrossRef
  31. null
    Zhi Ven Fong et al, 2021 CrossRef
  32. Risk of the Watch-and-Wait Concept in Surgical Treatment of Intraductal Papillary Mucinous Neoplasm
    Christine Tjaden et al, 2021, JAMA Surg CrossRef
  33. Cystic pancreatic lesions, the endless dilemma
    Hussein Hassan Okasha et al, 2021, WJG CrossRef
  34. Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know
    Ross C.D. Buerlein et al, 2021, Clin Med Insights Gastroenterol CrossRef
  35. Humoral Predictors of Malignancy in IPMN: A Review of the Literature
    Enrico C. Nista et al, 2021, IJMS CrossRef
  36. A deep learning algorithm to improve readers’ interpretation and speed of pancreatic cystic lesions on dual-phase enhanced CT
    Xiheng Wang et al, 2022, Abdom Radiol CrossRef
  37. Molecular Characterization and Pathogenesis of Intraductal Papillary Mucinous Neoplasms of the Pancreas
    Julia Benzel et al, 2015, Eur Surg Res CrossRef
  38. Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative Prognostic Factor for Intraductal Papillary Mucinous Neoplasms
    Shuji Suzuki et al, 2021, Eur Surg Res CrossRef
  39. Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative Surveillance
    J. de la Fuente et al, 2022, Gastro Hep Advances CrossRef
  40. Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms
    Yisheng Xu et al, 2022 CrossRef
  41. Pharmaconutrition: Which substrates?
    Luca Gianotti et al, 2022, European Journal of Surgical Oncology CrossRef
  42. Clinical and molecular attributes and evaluation of pancreatic cystic neoplasm
    Pratima Raut et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  43. Intraductal papillary mucinous neoplasm of pancreas: clinicopathological features and long-term survival after surgical resection
    Revoredo Rego Fernando et al, 2023, Cirugía Española (English Edition) CrossRef
  44. Diagnostic, Structured Classification and Therapeutic Approach in Cystic Pancreatic Lesions: Systematic Findings with Regard to the European Guidelines
    Christopher Kloth et al, 2023, Diagnostics CrossRef
  45. Neoplasia mucinosa papilar intraductal del páncreas: características clínico-patológicas y supervivencia a largo plazo de pacientes sometidos a pancreatectomía
    Fernando Revoredo Rego et al, 2023, Cirugía Española CrossRef
  46. Surveillance of Pancreatic Cystic Neoplasms
    Ankit Chhoda et al, 2023, Gastrointestinal Endoscopy Clinics of North America CrossRef
  47. Blood-Based Biomarkers in the Diagnosis and Risk Stratification of Pancreatic Cysts
    Matthew T. Peller et al, 2023, Gastrointestinal Endoscopy Clinics of North America CrossRef
  48. null
    Victoria Alejandra Jiménez-García et al, 2023 CrossRef
  49. Prediction of malignant intraductal papillary mucinous neoplasm: A nomogram based on clinical information and radiological outcomes
    Xiaorui Huang et al, 2023, Cancer Medicine CrossRef
  50. The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
    Iris J. M. Levink et al, 2023, UEG Journal CrossRef
  51. Monitoring Ca19‐9 during pancreatic cyst surveillance: Better safe than sorry?
    Giampaolo Perri et al, 2023, UEG Journal CrossRef
  52. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review
    Eizaburo Ohno et al, 2023, Pancreatology CrossRef
  53. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas
    Takao Ohtsuka et al, 2023, Pancreatology CrossRef
  54. Surgical outcomes of resected cystic neoplasms of pancreas: Experience from a tertiary care centre in India
    Digvijoy Sharma et al, 2023, Turk J Surg CrossRef
  55. Studies on Treatment Within the Scope of Medical Biotechnology for Pancreatic Diseases
    Dilara Aylar et al, 2024, Mol Biotechnol CrossRef
  56. International Evidence-based Kyoto Guidelines for the Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Dong Woo Shin, 2024, Korean J Gastroenterol CrossRef